Literature DB >> 10485343

A retrospective study of Creutzfeldt-Jakob disease in Belgium.

P Pals1, B Van Everbroeck, R Sciot, C Godfraind, W Robberecht, R Dom, C Laterre, J J Martin, P Cras.   

Abstract

Using data from Belgian neuropathological archives, completed with the results of a comprehensive study of available medical records, we found 100 patients who fulfilled diagnostic criteria for probable or definite Creutzfeldt-Jakob d1551isease (CJD). Mean age at death was 63 years. The median disease duration was 9 months. Progressive mental deterioration was present in all cases, whereas signs of cerebellar dysfunction and myoclonus were found in approximately 80% of the patients. In 50% of the population, the EEG revealed characteristic abnormalities. Ninety-six patients suffered from the sporadic type of CJD, while 4 suffered from a hereditary form. In our series, we could find no evidence for the new variant, neither for an iatrogenic cause.

Entities:  

Mesh:

Year:  1999        PMID: 10485343     DOI: 10.1023/a:1007581313067

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  13 in total

1.  Magnetic resonance imaging in Creutzfeldt-Jakob disease.

Authors:  T F Esmonde; R G Will
Journal:  Ann Neurol       Date:  1992-02       Impact factor: 10.422

2.  Diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  H A Kretzschmar; J W Ironside; S J DeArmond; J Tateishi
Journal:  Arch Neurol       Date:  1996-09

3.  Bovine spongiform encephalopathy and a new variant of Creutzfeldt-Jakob disease.

Authors:  L G Epstein; P Brown
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

4.  A retrospective study of Creutzfeldt-Jakob disease in Italy (1972-1986).

Authors:  C Masullo; M Pocchiari; G Neri; P Casaccia; A Iavarone; A Ladogana; G Macchi
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

5.  New variant of Creutzfeldt-Jakob disease in a 26-year-old French man.

Authors:  G Chazot; E Broussolle; C l Lapras; T Blättler; A Aguzzi; N Kopp
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

Review 6.  Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies.

Authors:  T Weber; M Otto; M Bodemer; I Zerr
Journal:  Biomed Pharmacother       Date:  1997       Impact factor: 6.529

7.  [Creutzfeldt-Jakob disease: diagnosis in 10 patients].

Authors:  F B van der Wurff; W A van Gool; A Hijdra
Journal:  Ned Tijdschr Geneeskd       Date:  1996-04-27

8.  Creutzfeldt-Jakob disease in France: I. Retrospective study of the Paris area during the ten-year period 1968-1977.

Authors:  P Brown; F Cathala
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

9.  Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.

Authors:  C L Masters; J O Harris; D C Gajdusek; C J Gibbs; C Bernoulli; D M Asher
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

10.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

View more
  4 in total

1.  Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

Authors:  B Van Everbroeck; A Michotte; R Sciot; C Godfraind; M Deprez; S Quoilin; J-J Martin; P Cras
Journal:  Eur J Epidemiol       Date:  2006-07-12       Impact factor: 8.082

Review 2.  Presenile dementia syndromes: an update on taxonomy and diagnosis.

Authors:  M D Greicius; M D Geschwind; B L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 3.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

4.  Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics.

Authors:  José Cortiñas Abrahantes; Marc Aerts; Bart van Everbroeck; Claude Saegerman; Dirk Berkvens; Helena Geys; Koen Mintiens; Stefan Roels; Patrick Cras
Journal:  Eur J Epidemiol       Date:  2007-06-21       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.